Taiwan-based Lotus Pharmaceutical Co. (TW: 1795) has announced a strategic licensing and commercialisation agreement with Alvotech, covering two of Alvotech’s
Read More
In a region where natural remedies are deeply rooted in culture, accelerated demand for nutraceuticals continues across Asia. Collectively worth some USD 35 billion, the three biggest consumer markets for nutraceuticals are those that have rapidly aging populations: Japan is the most established market; China is the fastest-growing market; and South Korea is the third-largest market.
Read More
At Vitafoods Asia, buyers can source products that address core and new health areas, such as combating the effects of pollution by using an oral nutraceutical.
Read More
Returning on 18- 20 March 2019 after a successful 2018 debut, Phar-East will once again bring together experts from Asian pharma & biotechs, big pharma, regulators, payers, technology innovators and more to share their expertise and chart Asia’s path forward.
Read More
Vitafoods Asia 2018 was a resounding success, bringing together the nutraceuticals industry from all parts of the globe to build valuable business connections. The exhibition grew by over 40% this year, and 2019 looks to expand further as 70% of the booths for the 2019 edition pre-sold at the show, with many of those exhibitors upsizing their stand space.
Read More
In the lead up to the Bio Connections Australia 13-14 November, Melbourne conference, we spoke with US-based pharmaceutical firm, Cerebral Therapeutics, who have recently undertaken a proof of concept clinical study in Australia, using a proprietary formulation to treat refractory epilepsy.
Read More